The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Athenex
Stock and Other Ownership Interests - Athenex
Travel, Accommodations, Expenses - Athenex
An open-label, fixed-sequence study to evaluate the effect of encequidar (HM30181) an oral P-gp inhibitor, on the pharmacokinetics of dabigatran etexilate (a P-gp substrate) in healthy male volunteers.
 
Christopher G. C. A. Jackson
Honoraria - Athenex; MSD Oncology
Research Funding - Athenex (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending - Oraxol - Athenex. No financial interest.
Travel, Accommodations, Expenses - Athenex
 
Noelyn Anne Hung
No Relationships to Disclose
 
David Cutler
Employment - Athenex
Stock and Other Ownership Interests - Athenex; Merck Sharp & Dohme
 
Douglas Kramer
Employment - Athenex
Stock and Other Ownership Interests - Athenex; DemeRx
 
Jay Zhi
Employment - Athenex
Stock and Other Ownership Interests - Athenex; Gilead Sciences
 
Wing Kai Chan
No Relationships to Disclose
 
Min-Fun Rudolf Kwan
Employment - Athenex
Leadership - Athenex
Stock and Other Ownership Interests - Athenex; GlaxoSmithKline; Merck/Schering Plough
Patents, Royalties, Other Intellectual Property - Multiple patents hold as employee of Athenex Inc, no royalties from any.
Travel, Accommodations, Expenses - Athenex
 
Tak Hung
No Relationships to Disclose